It had been identified that more recent agents with novel mechanisms of motion and improved protection profiles, including the melatonin agonists, hold promise to the management of Persistent sleeplessness in elderly men and women. Long-term utilization of sedative-hypnotic prescription drugs for the administration of sleeplessness does not have an